Team approach boosts weight loss in fatty liver disease
NCT ID NCT07366463
First seen Feb 01, 2026 · Last updated May 25, 2026 · Updated 12 times
Summary
This study tested a team-based approach for people with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), a type of fatty liver linked to heart risks. 286 adults received either standard care or extra support from a liver doctor, a nutritionist, and a psychologist. The goal was to help them lose at least 10% of their body weight and keep it off for 18 months, which can improve liver health and lower heart risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MASLD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Campania Luigi Vanvitelli
Naples, Campania, 80138, Italy
Conditions
Explore the condition pages connected to this study.